Cargando…

Prognostic Biomarkers after Radiotherapy for Nonsmall Cell Lung Cancer Based on Bioinformatics Analysis

Radiotherapy is one of the main treatment modalities in nonsmall cell lung cancer (NSCLC). However, tumor radiosensitivity is influenced by intrinsic factors like genetic variations and extrinsic factors like tumor microenvironment. Consequently, we hope to develop novel biomarkers, so as to improve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Kejun, Wang, Shuang, Li, Na, Zhao, Wenyue, He, Ningning, Wang, Jinhan, Ji, Kaihua, Zhang, Manman, Song, Huijuan, Liu, Qiang, Du, Liqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779995/ https://www.ncbi.nlm.nih.gov/pubmed/36567906 http://dx.doi.org/10.1155/2022/6405228

Ejemplares similares

Research Progress on the Biological Effects of Low-Dose Radiation in China
por: Ji, Kaihua, et al.
Publicado: (2019)

Radiation Responses of Human Mesenchymal Stem Cells Derived From Different Sources
por: He, Ningning, et al.
Publicado: (2019)

TAZ inhibition promotes IL-2-induced apoptosis of hepatocellular carcinoma cells by activating the JNK/F-actin/mitochondrial fission pathway
por: Ji, Kaihua, et al.
Publicado: (2018)

cIAP1/2 are involved in the radiosensitizing effect of birinapant on NSCLC cell line in vitro
por: Sun, Hao, et al.
Publicado: (2021)

Integrated Analysis of the Altered lncRNAs and mRNAs Expression in 293T Cells after Ionizing Radiation Exposure
por: Yang, Mengmeng, et al.
Publicado: (2019)

BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair
por: Kong, Yangyang, et al.
Publicado: (2022)

The Protection Effect of Resveratrol Against Radiation-Induced Inflammatory Bowel Disease via NLRP-3 Inflammasome Repression in Mice
por: Sun, Hao, et al.
Publicado: (2020)

Kremen2 drives the progression of non-small cell lung cancer by preventing SOCS3-mediated degradation of EGFR
por: Sun, Yuxiao, et al.
Publicado: (2023)

Cytogenetics data in adult men involved in the recycling of electronic wastes
por: Du, Yanan, et al.
Publicado: (2018)

Melatonin Sensitizes Human Colorectal Cancer Cells to γ-ray Ionizing Radiation In Vitro and In Vivo
por: Wang, Qin, et al.
Publicado: (2018)

MSCs inhibit tumor progression and enhance radiosensitivity of breast cancer cells by down-regulating Stat3 signaling pathway
por: He, Ningning, et al.
Publicado: (2018)

Analysis of Circular RNA Expression Profile in HEK 293T Cells Exposed to Ionizing Radiation
por: He, Ningning, et al.
Publicado: (2019)

A comprehensive bioinformatics analysis of FOXP3 in nonsmall cell lung cancer
por: Zhu, Jianfei, et al.
Publicado: (2022)

AGuIX nanoparticles enhance ionizing radiation-induced ferroptosis on tumor cells by targeting the NRF2-GPX4 signaling pathway
por: Sun, Hao, et al.
Publicado: (2022)

Analysis of changes to lncRNAs and their target mRNAs in murine jejunum after radiation treatment
por: Lu, Qianying, et al.
Publicado: (2018)

Ginger Oleoresin Alleviated γ-Ray Irradiation-Induced Reactive Oxygen Species via the Nrf2 Protective Response in Human Mesenchymal Stem Cells
por: Ji, Kaihua, et al.
Publicado: (2017)

Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma
por: Zhou, Lingqi, et al.
Publicado: (2018)

Prognostic Index for Nonsmall Cell Lung Cancer Based on Immune-Related Genes Expression
por: Cao, Ying, et al.
Publicado: (2022)

Serum Hsa_circ_0005962 Is A Prognostic Biomarker of Paclitaxel Resistance in Nonsmall Cell Lung Cancer Treatment
por: Wang, Chenliang, et al.
Publicado: (2023)

Gene Characteristics and Prognostic Values of m(6)A RNA Methylation Regulators in Nonsmall Cell Lung Cancer
por: Li, Na, et al.
Publicado: (2021)

Predictive biomarkers in nonsmall cell carcinoma and their clinico-pathological association
por: Mehta, Anurag, et al.
Publicado: (2019)

Macrophage Inhibitory Cytokine-1 as a Novel Diagnostic and Prognostic Biomarker in Stage I and II Nonsmall Cell Lung Cancer
por: Liu, Yu-Ning, et al.
Publicado: (2016)

A meta‐analysis: microRNAs’ prognostic function in patients with nonsmall cell lung cancer
por: Yu, Na, et al.
Publicado: (2017)

Molecular Mechanism of Expression Changes of Immunological Indexes of PD-1/sPD-L1 after Radiotherapy in Nonsmall Cell Lung Cancer
por: Qu, Yanli, et al.
Publicado: (2021)

Prognostic Impact of Sphingosine Kinase 1 in Nonsmall Cell Lung Cancer
por: Motono, Nozomu, et al.
Publicado: (2021)

miR-376a Provokes Rectum Adenocarcinoma Via CTC1 Depletion-Induced Telomere Dysfunction
por: Liu, Yang, et al.
Publicado: (2021)

The Prognostic Significance of the Histological Types in Patients With Nonsmall Cell Lung Cancer ≤2 cm
por: Hao, Bo, et al.
Publicado: (2021)

Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis
por: Zhou, Zengyuan, et al.
Publicado: (2019)

Bioinformatic screening for candidate biomarkers and their prognostic values in endometrial cancer
por: Li, Yaowei, et al.
Publicado: (2020)

Combining Bioinformatics Techniques to Study Diabetes Biomarkers and Related Molecular Mechanisms
por: Nie, Han, et al.
Publicado: (2020)

International guidelines on stage III N2 nonsmall cell lung cancer: surgery or radiotherapy?
por: Putora, Paul Martin, et al.
Publicado: (2020)

Clinical and prognostic significance of Merkel cell polyomavirus in nonsmall cell lung cancer
por: Kim, Gun-Jik, et al.
Publicado: (2017)

An IMRT/VMAT Technique for Nonsmall Cell Lung Cancer
por: Zhao, Nan, et al.
Publicado: (2015)

Bioinformatic Identification of Neuroblastoma Microenvironment-Associated Biomarkers with Prognostic Value
por: Wang, Yi, et al.
Publicado: (2020)

Identification of novel biomarkers in breast cancer via integrated bioinformatics analysis and experimental validation
por: Wang, Ningning, et al.
Publicado: (2021)

CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients
por: Kristiansen, G, et al.
Publicado: (2003)

Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer
por: Pelosi, G, et al.
Publicado: (2003)

Bone marrow micrometastasis in nonsmall cell lung cancer: A new prognostic marker?
por: Barbetakis, Nikolaos, et al.
Publicado: (2019)

Bmi-1 overexpression as an efficient prognostic marker in patients with nonsmall cell lung cancer
por: Zhang, Xiaojun, et al.
Publicado: (2017)

Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry
por: Metzenmacher, Martin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f5de66m1b6goinrgcu2qphj940